Reyon Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Reyon Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
Kukje Pharma Co Ltd
sales of 120.68 billion Korean Won [US$106.68 million]
of which 94%
Nutri Biotech Co Ltd
(120.78 billion Korean Won [US$106.77 million]
of which 100%
was Manufacture & Sales of Health Food), and
Hyundai Pharmaceutical Company Limited
(120.02 billion Korean Won [US$106.10 million]
of which 86%
During the year ended December of 2016, sales at
Reyon Pharmaceutical Co Ltd were 121.85 billion Korean Won (US$107.71 million).
increase of 6.4%
versus 2015, when the company's sales were 114.51 billion Korean Won.
This was the third consecutive year of growth at Reyon Pharmaceutical Co Ltd.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Reyon Pharmaceutical Co Ltd had sales
of 124.35 billion Korean Won.